换话题 发表于 2025-3-26 21:48:40

HBV Therapy and the Problem of Drug Resistancee risk of liver disease progression, including cirrhosis, hepatic failure, and hepatocellular carcinoma. Nucleos(t)ide analogue monotherapy is commonly used as first-line therapy, and most patients will require long-term antiviral therapy. As for all direct-acting antiviral agents, the emergence of

粗糙滥制 发表于 2025-3-27 02:05:31

Protease Inhibitor ResistanceV infection, allowing for viral elimination in the majority of treated patients. The first two drugs to be approved for the treatment of HCV genotype 1 infection were the HCV NS3/4A protease inhibitors telaprevir and boceprevir. However, their administration in combination with pegylated interferon

Communal 发表于 2025-3-27 08:27:47

http://reply.papertrans.cn/43/4209/420817/420817_33.png

法律 发表于 2025-3-27 09:55:50

Resistance to Cyclophilin Inhibitorst accomplished by combining several drugs with potent antiviral activity across multiple genotypes, with each possessing a high barrier to resistance, different mechanisms of action, and no cross-resistance. A novel class of anti-HCV agents that have shown great promise in HCV patients – the cycloph

共同给与 发表于 2025-3-27 15:07:25

Antiviral Drug Resistance in Herpesviruses) and varicella-zoster virus (VZV) infections. The modest activity of ACV against human cytomegalovirus (HCMV) has prompted the development of another nucleoside analogue, ganciclovir (GCV), for the management of systemic and organ-specific HCMV diseases. Second-line agents such as the pyrophosphate

狂热语言 发表于 2025-3-27 18:02:33

Quasispecies and Drug Resistance features of RNA viral quasispecies such as internal interactions within mutant spectra and the effect of population size and bottleneck events as they affect the frequency of inhibitor-escape mutants. Genetic barriers to resistance and fitness cost of specific amino acid substitutions involved in r

synovitis 发表于 2025-3-27 23:16:42

http://reply.papertrans.cn/43/4209/420817/420817_37.png

生命层 发表于 2025-3-28 06:03:57

The Mechanisms of Resistance to β-Lactam Antibiotics antibacterials is the β-lactams that target the transpeptidase enzymes, which are responsible for cross-linking the peptidoglycan cell wall. There are over 34 FDA-approved β-lactams which together constitute ~50 % of all antibiotic prescriptions worldwide (Tahlan K and Jensen SE, J Antibiot (Tokyo)

赞成你 发表于 2025-3-28 09:28:01

Antibiotic Resistance and Tolerance in Bacterial Biofilmss are ubiquitous in the natural and industrial environment, their importance in human infections has only been fully recognized in the past few decades. Biofilm-associated bacteria typically cause subacute and chronic infections. Many bacterial pathogens, such as . readily form biofilms, and . which

门闩 发表于 2025-3-28 14:01:37

Strategies for Circumventing Bacterial Resistance Mechanismsmised but is now found both in and out the boundaries of the hospital. Preserving the efficacy of the antibacterials we have, in order to secure the time needed to discover and develop new antibacterials, will require abrupt change: in the way antibacterials are dispensed and disposed, in the criter
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Handbook of Antimicrobial Resistance; Matthias Gotte (Editor-in-chief),Albert Berghuis,D Reference work 2017 Springer Science+Business Med